News

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. We identify and summarise the five top stories in quick-read format, so you have a full, clear and balanced picture of the latest advancements spanning diverse therapeutic areas and key development phases.
Interview with Professor Morten Meldal
Cell & Gene

Interview with Professor Morten Meldal

Thought Leadership Webinar: Ten Years of the Human Cell Atlas: A Decade Transforming Regenerative Medicine
Cell & Gene

Thought Leadership Webinar: Ten Years of the Human Cell Atlas: A Decade Transforming Regenerative Medicine

Interview with Andreas Plückthun
Proteins, Antibodies & ADCs

Interview with Andreas Plückthun

Interview with Alexander Eggermont
Cell & Gene

Interview with Alexander Eggermont

Delivering Next Generation Regenerative Medicine
Cell & Gene

Delivering Next Generation Regenerative Medicine

Top 25 of ’25: NextGen Biomed eBook

Top 25 of ’25: NextGen Biomed eBook

Ianalumab Effective for Immune Thrombocytopenia in Phase III
Proteins, Antibodies & ADCs

Ianalumab Effective for Immune Thrombocytopenia in Phase III

Breyanzi Gets Green Light from FDA for Marginal Zone Lymphoma

Breyanzi Gets Green Light from FDA for Marginal Zone Lymphoma

Understanding the CGT Investment Landscape: Interview with Sven Kili, Partner, Saisei Ventures
Cell & Gene

Understanding the CGT Investment Landscape: Interview with Sven Kili, Partner, Saisei Ventures

Avenzo Granted Fast Track Designation by FDA for Bispecific ADC

Avenzo Granted Fast Track Designation by FDA for Bispecific ADC

Tissue Engineering and Stem Cell Development: Insights from a Cell 2025 Roundtable
Cell & Gene

Tissue Engineering and Stem Cell Development: Insights from a Cell 2025 Roundtable

Navigating Regulatory Considerations for Cell and Gene Therapies: Insights from a Cell 2025 Roundtable
Cell & Gene

Navigating Regulatory Considerations for Cell and Gene Therapies: Insights from a Cell 2025 Roundtable

Ailux Partner with Lilly in $345m Deal to Advance Bispecific Antibody Development
Proteins, Antibodies & ADCs

Ailux Partner with Lilly in $345m Deal to Advance Bispecific Antibody Development

Caribou Announces Positive Data for Off-the-Shelf CAR T
Cell & Gene

Caribou Announces Positive Data for Off-the-Shelf CAR T

Designing Next Generation Biomaterials: Peptide Hydrogels for Culture, Printing & Regeneration
Cell & Gene

Designing Next Generation Biomaterials: Peptide Hydrogels for Culture, Printing & Regeneration

MIT Develop New Method of AAV Manufacture for Gene Therapy
Cell & Gene

MIT Develop New Method of AAV Manufacture for Gene Therapy

GSK Acquires Rights to ADC for Prostate Cancer for £268m
Proteins, Antibodies & ADCs

GSK Acquires Rights to ADC for Prostate Cancer for £268m

Gene Therapy Delivers Lasting Immune Protection to 59 Children with ADA-SCID
Cell & Gene

Gene Therapy Delivers Lasting Immune Protection to 59 Children with ADA-SCID

COVID Vaccines Mount Anti-Cancer Immune Response, Say Researchers in Boost for Universal Cancer Vaccine
Vaccines

COVID Vaccines Mount Anti-Cancer Immune Response, Say Researchers in Boost for Universal Cancer Vaccine

See Antibody Binding in 3D: How Cryo-EM Epitope Mapping Accelerates Antibody Discovery
Proteins, Antibodies & ADCs

See Antibody Binding in 3D: How Cryo-EM Epitope Mapping Accelerates Antibody Discovery

Bristol Myers Squibb Buys Orbital Therapeutics in $1.5b Deal

Bristol Myers Squibb Buys Orbital Therapeutics in $1.5b Deal

Boehringer Ingelheim to Enter $991 Million Partnership with AimedBio for ADC Targeting Broad Spectrum of Cancers
Proteins, Antibodies & ADCs

Boehringer Ingelheim to Enter $991 Million Partnership with AimedBio for ADC Targeting Broad Spectrum of Cancers

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.